Prednisolone mediated suppression of HIV-1 viral load strongly correlates with C-C chemokine CCL2: In vivo and in vitro findings

Clinical Immunology

Volumn 125, Issue 1, 2007, Pages 1-4

  Ansari, Abdul Wahid ^a   Schmidt, Reinhold E ^a   Heiken, Hans ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Anti inflammatory; CCL2; HIV 1; Prednisolone; Viremia

Indexed keywords

CHEMOKINE; EFAVIRENZ; GREEN FLUORESCENT PROTEIN; LAMIVUDINE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PREDNISOLONE; PREDNISOLONE SODIUM SUCCINATE; ZIDOVUDINE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CASE REPORT; DISEASE SEVERITY; DRUG MEGADOSE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; UVEITIS; VIREMIA; VIRUS INHIBITION; VIRUS LOAD; VIRUS REPLICATION;

ANTI-HIV AGENTS; ANTI-INFLAMMATORY AGENTS; BENZOXAZINES; CHEMOKINE CCL2; DRUG RESISTANCE, VIRAL; FLOW CYTOMETRY; GENE EXPRESSION; HIV INFECTIONS; HIV-1; HUMANS; INTERLEUKIN-8; LAMIVUDINE; MALE; PREDNISOLONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; UVEITIS; VIRAL LOAD; VIREMIA; ZIDOVUDINE;

EID: 34548508678     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2007.07.003     Document Type: Article

References (20)

1. Ansari A.W., Bhatnagar N., Dittrich-Breiholz O., Kracht M., Schmidt R.E., and Heiken H. Host chemokine (C-C motif) ligand-2 (CCL2) is differentially regulated in HIV type 1 (HIV-1)-infected individuals. Int. Immunol. 18 (2006) 1443-1451
2. Carr M.W., Roth S.J., Luther E., Rose S.S., and Springer T.A. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 3652-3656
3. Matsushima K., Larsen C.G., DuBois G.C., and Oppenheim J.J. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J. Exp. Med. 169 (1989) 1485-1490
4. Mengozzi M., De Filippi C., Transidico P., Biswas P., Cota M., Ghezzi S., Vicenzi E., Mantovani A., Sozzani S., and Poli G. Human immunodeficiency virus replication induces monocyte chemotactic protein-1 in human macrophages and U937 promonocytic cells. Blood 93 (1999) 1851-1857
5. Kinter A., Catanzaro A., Monaco J., Ruiz M., Justement J., Moir S., Arthos J., Oliva A., Ehler L., Mizell S., Jackson R., Ostrowski M., Hoxie J., Offord R., and Fauci A.S. CC-chemokines enhance the replication of T-tropic strains of HIV-1 in CD4(+) T cells: role of signal transduction. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 11880-11885
6. Kino T., Kopp J.B., and Chrousos G.P. Glucocorticoids suppress human immunodeficiency virus type-1 long terminal repeat activity in a cell type-specific, glucocorticoid receptor-mediated fashion: direct protective effects at variance with clinical phenomenology. J. Steroid Biochem. Mol. Biol. 75 (2000) 283-290
7. Russo F.O., Patel P.C., Ventura A.M., and Pereira C.A. HIV-1 long terminal repeat modulation by glucocorticoids in monocytic and lymphocytic cell lines. Virus Res. 64 (1999) 87-94
8. Douek D.C., Picker L.J., and Koup R.A. T cell dynamics in HIV-1 infection. Annu. Rev. Immunol. 21 (2003) 265-304
9. Aukrust P., Liabakk N.B., Muller F., Lien E., Espevik T., and Froland S.S. Serum levels of tumor necrosis factor-alpha (TNF alpha) and soluble TNF receptors in human immunodeficiency virus type 1 infection-correlations to clinical, immunologic, and virologic parameters. J. Infect. Dis. 169 (1994) 420-424
10. Herbein G., Keshav S., Collin M., Montaner L.J., and Gordon S. HIV-1 induces tumour necrosis factor and IL-1 gene expression in primary human macrophages independent of productive infection. Clin. Exp. Immunol. 95 (1994) 442-449
11. Merrill J.E., Koyanagi Y., and Chen I.S. Interleukin-1 and tumor necrosis factor alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor. J. Virol. 63 (1989) 4404-4408
12. Esser R., Glienke W., von Briesen H., Rubsamen-Waigmann H., and Andreesen R. Differential regulation of proinflammatory and hematopoietic cytokines in human macrophages after infection with human immunodeficiency virus. Blood 88 (1996) 3474-3481
13. Matsumoto T., Miike T., Nelson R.P., Trudeau W.L., Lockey R.F., and Yodoi J. Elevated serum levels of IL-8 in patients with HIV infection. Clin. Exp. Immunol. 93 (1993) 149-151
14. Auphan N., DiDonato J.A., Rosette C., Helmberg A., and Karin M. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270 (1995) 286-290
15. Scheinman R.I., Cogswell P.C., Lofquist A.K., and Baldwin Jr. A.S. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 270 (1995) 283-286
16. Mitra D., Sikder S.K., and Laurence J. Role of glucocorticoid receptor binding sites in the human immunodeficiency virus type 1 long terminal repeat in steroid-mediated suppression of HIV gene expression. Virology 20 214 (1995) 512-521
17. Andrieu J.M., and Lu W. Long-term clinical, immunologic and virologic impact of glucocorticoids on the chronic phase of HIV infection. BMC Med. 2 (2004) 17
18. McComsey G.A., Whalen C.C., Mawhorter S.D., Asaad R., Valdez H., Patki A.H., Klaumunzner J., Gopalakrishna K.V., Calabrese L.H., and Lederman M.M. Placebo-controlled trial of prednisone in advanced HIV-1 infection. AIDS 15 (2001) 321-327
19. Wallis R.S., Kalayjian R., Jacobson J.M., Fox L., Purdue L., Shikuma C.M., Arakaki R., Snyder S., Coombs R.W., Bosch R.J., Spritzler J., Chernoff M., Aga E., Myers L., Schock B., and Lederman M.M. A study of the immunology, virology, and safety of prednisone in HIV-1-infected subjects with CD4 cell counts of 200 to 700 mm(- 3). J. Acquir. Immune Defic. Syndr. 32 (2003) 281-286
20. Gu L., Tseng S., Horner R.M., Tam C., Loda M., and Rollins B.J. Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 404 (2000) 407-411